Vascularization of wide pore agarose-gelatin cryogel scaffolds implanted subcutaneously in diabetic and non-diabetic mice.
Polymeric scaffolds have been reported to promote angiogenesis, facilitating oxygen delivery; however, little is known about the effect of diabetes on the neo-vascularization of implanted polymeric scaffolds at subcutaneous (SC) sites. In this study we compare the effect of diabetes on scaffold vascularization following SC implantation into diabetic and non-diabetic mice. Wide pore agarose cryogel scaffolds with grafted gelatin were prepared by a two-step freezing procedure and subsequent thawing. The scaffolds were implanted subcutaneously into streptozoticin-induced diabetic mice and control, non-diabetic mice. The vascularization process was estimated using histological sections, in which endothelial cells were identified by Von Willebrand factor (vWF) and CD31 antigen staining and the pericyte layer was confirmed by alpha-smooth muscle actin (alpha-SMA) visualization. Comparative analysis showed a similar thickness of fibrous capsules around the vascularized scaffolds in both diabetic and non-diabetic animals. Intensive staining for alpha-SMA indicated the formation of mature blood vessels in the surrounding fibrous capsule and tissue invading the scaffold area. No statistically significant differences in capillary density and area occupied by blood vessels were found between diabetic and non-diabetic mice. In conclusion, the present study shows no adverse effects of diabetes on new blood vessel formation in SC implanted agarose cryogel scaffolds with grafted gelatin.
Bloch
K
K
Diabetes and Obesity Research Laboratory, Felsenstein Medical Research Center, Sackler Faculty of Medicine, Tel-Aviv University, Petah Tikva 49100, Israel. kbloch@post.tau.ac.il
Vanichkin
A
A
Damshkaln
L G
LG
Lozinsky
V I
VI
Vardi
P
P
D000818:Animals; D001672:Biocompatible Materials / Q000737:chemistry; D001808:Blood Vessels / Q000254:growth & development*; D018929:Cell Culture Techniques / Q000379:methods; D059985:Cryogels; D003921:Diabetes Mellitus, Experimental / Q000139:chemically induced / Q000473:pathology / Q000601:surgery*; D005780:Gelatin / Q000737:chemistry*; D020100:Hydrogels / Q000737:chemistry*; D008422:Materials Testing; D051379:Mice; D008813:Mice, Inbred ICR; D018919:Neovascularization, Physiologic / Q000502:physiology; D016062:Porosity; D019736:Prostheses and Implants; D012685:Sepharose / Q000737:chemistry*; D013311:Streptozocin; D023822:Tissue Engineering / Q000379:methods; D054457:Tissue Scaffolds / Q000737:chemistry*; D016896:Treatment Outcome
D001672:Biocompatible Materials; D059985:Cryogels; D020100:Hydrogels; D013311:Streptozocin; D005780:Gelatin; D012685:Sepharose